logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report

O'Brien DP, Athan E, Hughes AJ, Johnson PD
2008-06-01 • Journal of Medical Case Reports
2008-06-01 • Journal of Medical Case Reports
ABSTRACT: INTRODUCTION: Treatment for osteomyelitis-complicating Mycobacterium ulcerans infection typically requires extensive surgery and even amputation, with no reported benefit from ...
Journal Article
|
Research

Mycobacterium Ulcerans Treatment – Can Antibiotic Duration Be Reduced in Selected Patients? (D/N include in MSF Publications analysis)

Cowan R, Athan E, Friedman ND, Hughes AJ, McDonald AH,  et al.
2015-02-06 • PLOS Neglected Tropical Diseases
2015-02-06 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Impact of HIV-Associated Conditions on Mortality in People Commencing Anti-Retroviral Therapy in Resource Limited Settings

Marshall C, Curtis A, Spelman T, O'Brien DP, Greig J,  et al.
2013-07-23 • PLOS One
2013-07-23 • PLOS One
To identify associations between specific WHO stage 3 and 4 conditions diagnosed after ART initiation and all cause mortality for patients in resource-limited settings (RLS). DESIGN, SET...
Journal Article
|
Research

Mycobacterium ulcerans treatment - can antibiotic duration be reduced in selected patients?

Cowan R, Athan E, Friedman ND, Hughes AJ, McDonald AH,  et al.
2015-02-06 • PLOS Neglected Tropical Diseases
2015-02-06 • PLOS Neglected Tropical Diseases
INTRODUCTION
Mycobacterium ulcerans (M. ulcerans) is a necrotizing skin infection endemic to the Bellarine Peninsula, Australia. Current treatment recommendations include 8 weeks of ...